Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search
Fullscreen

For citation:


Mazina N.K., Mazin P.V. Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2017;10(3):12-21. (In Russ.) https://doi.org/10.17749/2070-4909.2017.10.3.012-021

Views: 56


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)